ICAM1 and myocardial infarction: Similarly, Luc et al compared 317 men to 613 matched controls; adjusted baseline levels of ICAM-1 were associated with an increased relative risk(RR) for myocardial infarction (RR 1.34; 95% CI 1.07–1.67) over 5 years [30].